Karvezide

Hydrochlorothiazide / Irbesartan, the active ingredients in Karvezide, constitute an Angiotensin II receptor blocker / Thiazide diuretic combination presented as oral tablets. The combination is indicated for the management of hypertension in adult patients, helping to achieve target blood pressure levels.

GNH USA supplies Karvezide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality manufacturing, regulatory compliance and reliable global distribution to meet the needs of healthcare providers.

Karvezide, a combination antihypertensive, acts on the renin‑angiotensin system and renal sodium handling to control high blood pressure.

Hypertension: lowers blood pressure and reduces risk of cardiovascular complications. Essential hypertension: provides blood pressure control in primary hypertension. Secondary hypertension: assists in managing blood pressure when caused by renal or endocrine disorders.

Karvezide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Increased urinary frequency - Electrolyte imbalance (e.g., low potassium) - Mild gastrointestinal upset

Serious or Rare Side Effects: - Severe dehydration or electrolyte disturbances - Acute kidney injury or worsening renal function - Angioedema or severe allergic reaction - Marked hypotension - Hyperkalemia when combined with potassium‑sparing agents - Hepatic dysfunction (rare)

Before initiating therapy, clinicians should consider several safety aspects.

Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. Electrolyte assessment: regularly monitor serum potassium and sodium levels. Renal function: evaluate creatinine and glomerular filtration rate, especially in patients with pre‑existing kidney disease. Pregnancy: avoid use unless the potential benefit justifies the risk to the fetus. Drug interactions: review concomitant medications for possible additive effects. Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Karvezide can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Lithium: concomitant use may increase lithium serum concentrations. - NSAIDs: may blunt the antihypertensive effect and affect renal function.

Moderate Interactions (Monitor Closely): - ACE inhibitors: additive blood‑pressure lowering effect. - Other antihypertensives (e.g., beta‑blockers, calcium channel blockers): increased risk of hypotension. - CYP2C9 inhibitors (e.g., fluconazole, amiodarone): may raise irbesartan plasma levels.